Determinants and Clinical Outcomes of Extended Dual Antiplatelet Therapy over 3 Years after Drug-Eluting Stent Implantation: A Retrospective Analysis

PURPOSE: Although current guidelines recommend the administration of dual antiplatelet therapy (DAPT) for up to 12 months after the implantation of a drug-eluting stent (DES), extended DAPT is frequently used in real-world practice. MATERIALS AND METHODS: From the Korean Multicenter Angioplasty Team...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Oh-Hyun, Kim, Byeong-Keuk, Hong, Sung-Jin, Kim, Seunghwan, Ahn, Chul-Min, Shin, Dong-Ho, Kim, Jung-Sun, Kang, Tae Soo, Ko, Young-Guk, Choi, Donghoon, Hong, Myeong-Ki, Jang, Yangsoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329747/
https://www.ncbi.nlm.nih.gov/pubmed/32608203
http://dx.doi.org/10.3349/ymj.2020.61.7.597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329747/
https://www.ncbi.nlm.nih.gov/pubmed/32608203
http://dx.doi.org/10.3349/ymj.2020.61.7.597

Ejemplares similares